Agenus Inc Corporate Update and Financial Results for Q2 2021. See Also: Why Intellia Was Down Today

Agenus Inc News and Q2 Results for 201
Agenus (AGEN) announced results with better than usual news including the following: 

  • $200 million received from BMS for anti-TIGIT bispecific antibody collaboration
  • FDA cleared IND for AGEN1777 clinical enrollment
  • AGEN1181 rapidly advancing in the clinic - data to be presented in 2H 2021
  • Cell therapy . . .
    This content is for paid subscribers.
    Please click here to subscribe or here to log in.